United States Antihypertensive Drug Market Report to 2021

United States Antihypertensive Drug Market Report 2021

1 Antihypertensive Drug Overview

1.1 Product Overview and Scope of Antihypertensive Drug

1.2 Classification of Antihypertensive Drug

1.2.1 Central Antihypertensive Drug

1.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

1.2.3 Ganglion Block Drugs

1.2.4 Vasodilators

1.2.5 Adrenergic Alpha 1 Receptor Antagonist

1.2.6 Drugs that Affect the Renin-angiotensin-aldosterone System

1.2.7 Calcium Channel Blockers

1.3 Applications of Antihypertensive Drug

1.3.1 First Level Hospital

1.3.2 Two Level Hospital

1.3.3 Three Level Hospital

1.3.4 Others

1.4 USA Market Size (Value and Volume) of Antihypertensive Drug (2011-2021)

1.4.1 USA Antihypertensive Drug Sales, Revenue and Price (2011-2021)

1.4.2 USA Antihypertensive Drug Sales and Growth Rate (2011-2021)

1.4.3 USA Antihypertensive Drug Revenue and Growth Rate (2011-2021)

2 USA Antihypertensive Drug Competition by Manufacturers

2.1 USA Antihypertensive Drug Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Antihypertensive Drug Revenue and Share by Manufactures (2015 and 2016)

3 USA Antihypertensive Drug (Volume and Value) by Type

3.1 USA Antihypertensive Drug Sales and Market Share by Type (2011-2021)

3.2 USA Antihypertensive Drug Revenue and Market Share by Type (2011-2021)

4 USA Antihypertensive Drug (Volume) by Application

5 USA Antihypertensive Drug Manufacturers Analysis

5.1 Novartis

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Antihypertensive Drug Product Type and Technology

5.1.2.1 Central Antihypertensive Drug

5.1.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

5.1.3 Antihypertensive Drug Sales, Revenue, Price of Novartis (2015 and 2016)

5.2 Pfizer, Inc.

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharmaceuticals Product Type and Technology

5.2.2.1 Central Antihypertensive Drug

5.2.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

5.2.3 Pharmaceuticals Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)

5.3 Roche

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Roche Product Type and Technology

5.3.2.1 Central Antihypertensive Drug

5.3.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

5.3.3 Roche Sales, Revenue, Price of Roche (2015 and 2016)

5.4 Sanofi

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Eli Lilly and Company Product Type and Technology

5.4.2.1 Central Antihypertensive Drug

5.4.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

5.4.3 Sanofi Sales, Revenue, Price of Sanofi (2015 and 2016)

5.5 Merck & Co., Inc.

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Merck & Co., Inc. Product Type and Technology

5.5.2.1 Central Antihypertensive Drug

5.5.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

5.5.3 Merck & Co., Inc. Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)

5.6 GlaxoSmithKline plc

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 GlaxoSmithKline plc Product Type and Technology

5.6.2.1 Central Antihypertensive Drug

5.6.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

5.6.3 GlaxoSmithKline plc Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)

5.7 Johnson & Johnson

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Johnson & Johnson Product Type and Technology

5.7.2.1 Central Antihypertensive Drug

5.7.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

5.7.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

5.8 AstraZeneca plc.

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 AstraZeneca plc. Product Type and Technology

5.8.2.1 Central Antihypertensive Drug

5.8.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

5.8.3 AstraZeneca plc. Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)

5.9 Eli Lilly and Company

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Eli Lilly and Company Product Type and Technology

5.9.2.1 Central Antihypertensive Drug

5.9.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

5.9.3 Eli Lilly and Company Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)

5.10 Abbvie

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Abbvie Product Type and Technology

5.10.2.1 Central Antihypertensive Drug

5.10.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System

5.10.3 Abbvie Sales, Revenue, Price of Abbvie (2015 and 2016)

5.11 AMGen

5.12 Teva Pharmaceutical Industries Ltd.

5.13 Bayer AG

5.14 Bristol-Myers Squibb

5.15 Astellas Pharma

5.16 Daiichi Sankyo

5.17 Abbott Laboratories

5.18 Yangtze River Pharmaceutical Group

5.19 Boehringer-Ingelheim

6 Antihypertensive Drug Technology and Development Trend

6.1 Antihypertensive Drug Technology Analysis

6.2 Antihypertensive Drug Technology Development Trend

7 Research Findings and Conclusion

Figure Picture of Antihypertensive Drug

Table Classification of Antihypertensive Drug

Figure USA Sales Market Share of Antihypertensive Drug by Type in 2015

Figure Central Antihypertensive Drug Picture

Figure An Antihypertensive Agent Acting on the Sympathetic Nervous System Picture

Figure Ganglion Block Drugs Picture

Figure Vasodilators Picture

Figure Adrenergic Alpha 1 Receptor Antagonist Picture

Figure Drugs that Affect the Renin-angiotensin-aldosterone System Picture

Figure Calcium Channel Blockers Picture

Table Applications of Antihypertensive Drug

Figure USA Sales Market Share of Antihypertensive Drug by Application in 2015

Figure First Level Hospital Examples

Figure Two Level Hospital Examples

Figure Three Level Hospital Examples

Figure Others Examples

Table USA Antihypertensive Drug Sales, Revenue and Price (2011-2021)

Figure USA Antihypertensive Drug Sales and Growth Rate (2011-2021)

Figure USA Antihypertensive Drug Revenue and Growth Rate (2011-2021)

Table USA Antihypertensive Drug Sales of Key Manufacturers (2015 and 2016)

Table USA Antihypertensive Drug Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Antihypertensive Drug Sales Share by Manufacturers

Figure 2016 Antihypertensive Drug Sales Share by Manufacturers

Table USA Antihypertensive Drug Revenue by Manufacturers (2015 and 2016)

Table USA Antihypertensive Drug Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Antihypertensive Drug Revenue Share by Manufacturers

Table 2016 USA Antihypertensive Drug Revenue Share by Manufacturers

Table USA Antihypertensive Drug Sales and Market Share by Type (2011-2021)

Table USA Antihypertensive Drug Sales Share by Type (2011-2021)

Figure Sales Market Share of Antihypertensive Drug by Type (2011-2021)

Figure USA Antihypertensive Drug Sales Growth Rate by Type (2011-2021)

Table USA Antihypertensive Drug Revenue and Market Share by Type (2011-2021)

Table USA Antihypertensive Drug Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Antihypertensive Drug by Type (2011-2021)

Figure USA Antihypertensive Drug Revenue Growth Rate by Type (2011-2021)

Table USA Antihypertensive Drug Sales and Market Share by Application (2011-2021)

Table USA Antihypertensive Drug Sales Share by Application (2011-2021)

Figure Sales Market Share of Antihypertensive Drug by Application (2011-2021)

Figure USA Antihypertensive Drug Sales Growth Rate by Application (2011-2021)

Table Novartis Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Novartis (2015 and 2016)

Table Pfizer, Inc. Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)

Table Roche Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Roche (2015 and 2016)

Table Sanofi Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Sanofi (2015 and 2016)

Table Merck & Co., Inc. Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)

Table GlaxoSmithKline plc Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table AstraZeneca plc. Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)

Table Eli Lilly and Company Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)

Table Abbvie Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Abbvie (2015 and 2016)

Table AMGen Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of AMGen (2015 and 2016)

Table Teva Pharmaceutical Industries Ltd. Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)

Table Bayer AG Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Bayer AG (2015 and 2016)

Table Bristol-Myers Squibb Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)

Table Astellas Pharma Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Astellas Pharma (2015 and 2016)

Table Daiichi Sankyo Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)

Table Abbott Laboratories Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)

Table Yangtze River Pharmaceutical Group Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)

Table Boehringer-Ingelheim Basic Information List

Table Antihypertensive Drug Sales, Revenue, Price of Boehringer-Ingelheim (2015 and 2016)